13-Valent Pneumococcal conjugate vaccine Prevenar 13®

    Pneumococcal infection refers to the Streptococcus pneumoniae (pneumococcal) disease caused by. Although pneumococcal normally will only cause sinusitis and otitis media, but it may also lead to serious and even deadly invasive pneumococcal diseases, including pneumonia, septicaemia and meningitis. Invasive pneumococcal disease in young children and the elderly are usually more serious consequences

    Prevenar 13® , a pneumococcal conjugate vaccine, adopts the latest conjugation technology and provides long lasting protection with one convenient dose to individuals 2 years old and above. It is included in the Hong Kong Childhood Immunization Programme for children aged below 2 and recommended by Hong Kong Centre for Health Protection for elders aged over 65. US Centers for Disease Control and Prevention also recommends

    Prevenar 13 for use as a priority pneumococcal vaccine among elders aged over 65.
    Apply age -2 aged or above, for those who have not receivedPrevenar 13®, only one dose

    Number covers the Qing -13 species : 1, 3, 4, 5, 6, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
    Vaccine characteristics – based vaccine technology can lead to immunological memory, providing long-lasting protection





    Data source:Pfizer